// App-Quantinova.ai

: Characterization of FOLH1 expression in renal cell carcinoma (RCC).

Researchers

Presenter

  • Elizabeth Pan

Principal Investigators

  • Andrew Elliott

  • Shankar Siva

  • Praful Ravi

  • Bradley Alexander McGregor

  • Toni K. Choueiri

  • Aditya Bagrodia

  • Ithaar Derweesh

  • Pedro C. Barata

  • Elisabeth I. Heath

  • Emmanuel S. Antonarakis

  • Sourat Darabi

  • Dave S. Hoon

  • Amir Mortazavi

  • Phillip Walker

  • Chadi Nabhan

  • W. Michael Korn

  • Rana R. McKay

Medical Centers

  • John Wayne Cancer Institute, Santa Monica, CA

  • UCSD, San Diego, CA

  • Tulane University, New Orleans, LA

  • Hoag Hosp, Newport Beach, CA

  • Caris Life Sciences, Phoenix, AZ

  • Barbara Ann Karmanos Cancer Institute, Detroit, MI

  • University of Minnesota Physician's Oncology Clinics, Minneapolis, MN

  • The Ohio State University Comprehensive Cancer Center, Division of Radiation Oncology, Columbus, OH

  • Dana-Farber Cancer Institute, Boston, MA

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

  • University of California, San Diego, La Jolla, CA

Locations

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

Biomarkers

  • Programmed death-ligand 1

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved